- Difficulty breathing or very slow breathing
- Chest pain or irregular heartbeat
- Seizures
- Severe confusion, disorientation, or delirium
- Loss of consciousness or cannot be roused
- Suicidal thoughts or intent to self-harm
- Signs of severe dehydration (no urination for many hours, severe dizziness, extreme weakness)
These symptoms are not typical opioid withdrawal. They require emergency medical evaluation immediately.
Most uncomplicated opioid withdrawal — in a person withdrawing from opioids alone, without significant medical history — can be managed outside a hospital setting with appropriate support. However, several factors change that picture significantly, and some warning signs require emergency care.
This page explains when home management is not appropriate, what to watch for, how polysubstance withdrawal differs, and how to access treatment.
Quick Answer
Medical evaluation is recommended or required when: withdrawal is unusually severe, dehydration is a risk, other substances (especially alcohol or benzodiazepines) are involved, significant medical or psychiatric conditions are present, or the person is pregnant. Emergency services are needed for breathing difficulties, seizures, severe confusion, loss of consciousness, or suicidal thoughts.
When Home Management Is Not Appropriate
Opioid withdrawal without medical supervision is higher risk in any of the following situations:
- Polysubstance use: Co-withdrawal from alcohol, benzodiazepines, or other sedatives is potentially life-threatening and requires medical supervision. Opioid withdrawal alone rarely causes death; combined with alcohol or benzodiazepine withdrawal, the risk profile changes dramatically.
- Pregnancy: Opioid withdrawal during pregnancy carries risks to the fetus. Pregnant people should never attempt unsupervised withdrawal. Buprenorphine and methadone are the recommended medications during pregnancy. [1]
- Significant medical conditions: Cardiovascular disease, kidney disease, liver disease, diabetes, or severe psychiatric illness all increase the complexity and risk of withdrawal.
- Severe symptoms: Vomiting or diarrhea severe enough to prevent adequate hydration; pain or agitation severe enough to impair function.
- Uncertainty about what substances are involved: If there is any uncertainty about whether illicit fentanyl, xylazine, or adulterants are involved, clinical evaluation is warranted.
- Prior history of withdrawal complications: If a previous withdrawal involved seizures, severe cardiovascular events, or psychiatric crises, this warrants supervised management.
- Lack of adequate support: Safe home withdrawal requires someone to check on the person, provide fluids, and watch for warning signs. If this is not possible, clinical setting is preferable.
Emergency Warning Signs
The following symptoms are not typical of uncomplicated opioid withdrawal and require immediate emergency evaluation:
Respiratory
- Difficulty breathing or shortness of breath
- Slow or labored breathing (not anxiety-related rapid breathing)
Cardiovascular
- Chest pain or pressure
- Irregular or very rapid heartbeat beyond typical withdrawal tachycardia
- Fainting or near-fainting
Neurological
- Seizures (not expected in opioid-only withdrawal; common in alcohol/benzodiazepine withdrawal)
- Severe confusion, disorientation, or inability to recognize people or surroundings
- Loss of consciousness
Psychiatric
- Suicidal thoughts or intent
- Severe psychiatric symptoms (psychosis, hallucinations)
- Inability to care for oneself due to psychological symptoms
Dehydration
- No urination for 8+ hours
- Extreme dizziness when standing (orthostatic hypotension)
- Inability to keep any fluids down for more than a few hours
- Confusion related to dehydration
Why Polysubstance Withdrawal Is Different
This deserves specific emphasis because it is one of the most dangerous aspects of withdrawal management that is frequently underappreciated.
Opioids + Alcohol
Alcohol withdrawal syndrome (AWS) can produce seizures and delirium tremens — a life-threatening condition. A person withdrawing from both opioids and alcohol simultaneously is at risk for AWS even if they are focused on the opioid withdrawal. Medical supervision is required.
Opioids + Benzodiazepines
Benzodiazepine withdrawal shares some features with alcohol withdrawal and carries significant risks including seizures. Combined withdrawal is complex and should be medically managed.
Opioids + Sedatives
Any co-use of CNS depressants (including sleep medications, muscle relaxants, or other sedatives) complicates the withdrawal picture and increases risk.
Opioids + Stimulants
Stimulant withdrawal (from cocaine, methamphetamine, etc.) is not typically medically dangerous, but it intensifies the psychological aspects of withdrawal — particularly depression and dysphoria — and should be considered in the clinical picture.
When to Ask About Medications for OUD (MOUD)
Any clinical encounter during or around opioid withdrawal is an opportunity to discuss medications for opioid use disorder. SAMHSA identifies buprenorphine, methadone, and naltrexone as FDA-approved medications for OUD, and evidence supports their use for reducing cravings, preventing relapse, and improving long-term outcomes. [2]
What to Tell a Clinician
To help a clinician provide the best care, share as much of the following as you can:
- What opioid(s) you were using (including any illicit substances)
- Approximate dose and frequency of use
- How long you have been using at this level
- Route of use (oral, intranasal, intravenous)
- Last dose and when withdrawal symptoms started
- Other substances you use (including alcohol, benzodiazepines, cannabis)
- Current medications and any known medical conditions
- Previous withdrawal experiences and any complications
- Any prior treatment (including MOUD)
- Current symptoms and their severity
What to Bring to an Appointment
- A list of current medications
- Any prescription bottles you have
- Insurance information or identification
- A trusted person for support if possible
- Notes about your symptoms and timeline
Finding Treatment
Several resources can help locate clinical support:
- SAMHSA National Helpline: 1-800-662-4357 (free, confidential, 24/7). Can refer you to local treatment programs, including buprenorphine prescribers and methadone clinics.
- FindTreatment.gov: findtreatment.gov — a searchable directory of treatment programs by location.
- SAMHSA Buprenorphine Prescriber Locator: samhsa.gov
- Emergency departments: Many emergency departments now have addiction medicine consultants or can initiate buprenorphine for opioid withdrawal management.
Common Questions
Is it safe to withdraw from opioids at home?
For uncomplicated opioid withdrawal — no other substances, no significant medical history, adequate support and hydration available — many people manage at home. However, this carries meaningful risk, especially around relapse and the resulting drop in tolerance. Clinical support significantly improves both safety and outcomes.
What will happen at the hospital during withdrawal?
Clinical management typically focuses on: monitoring vital signs, treating specific symptoms (anti-nausea medications, anti-diarrheal medications, clonidine for autonomic symptoms, fluids for dehydration), ensuring safety, and offering referral to ongoing treatment including MOUD.
What if I don't have insurance?
SAMHSA’s helpline (1-800-662-4357) can help identify sliding-scale and no-cost treatment options. Many community health centers provide addiction medicine services regardless of insurance status. State-funded programs also exist in most states.
Key Takeaways
- Opioid withdrawal alone is rarely immediately life-threatening — but several situations require medical care.
- Emergency symptoms (breathing difficulty, seizures, severe confusion, suicidal thoughts) require 911 immediately.
- Polysubstance withdrawal — especially with alcohol or benzodiazepines — is medically serious and requires clinical supervision.
- Pregnancy, significant medical history, and severe symptoms all warrant clinical evaluation before attempting withdrawal.
- Any clinical encounter is an opportunity to discuss MOUD (buprenorphine, methadone, naltrexone).
- SAMHSA’s helpline (1-800-662-4357) and FindTreatment.gov are free resources for locating care.
Related Resources
Sources
- ACOG (American College of Obstetricians and Gynecologists). Opioid Use and Opioid Use Disorder in Pregnancy. Committee Opinion No. 711. 2017. ACOG.org
- SAMHSA. Medications for Opioid Use Disorder: Treatment Improvement Protocol (TIP) 63. 2021. SAMHSA.gov
- CDC. Evidence-Based Overdose Prevention Strategies. CDC.gov
- Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760-773.
This page provides general educational information. It is not a substitute for clinical evaluation. In any emergency, call 911 immediately.
